FIRM FIXED PRICE

ACTELION PHARMACEUTICALS US, INC. - OPSUMIT 10MG-QTY 2 @ 6,270.03

PIID: 15B50526F00000010
Signed Date: Oct 17, 2025Effective Date: Oct 31, 2025End Date: Closed on Oct 31, 2025
Vendor
ACTELION PHARMACEUTICALS US, INC.
NAICS
325412
Signed Date
Oct 17, 2025

Key Details

Dollars Obligated
Base & All Options
$12,540.06
Awarding Agency
Department of Justice
Awarding Sub-Agency
Federal Prison System / Bureau of Prisons
Product Service Code
Q517 - PHARMACY SERVICES
Extent Competed
FULL AND OPEN COMPETITION
Number of Offers
1
Place of Performance
TITUSVILLE, NJ, 085601504, CD-NJ-12

Description

OPSUMIT 10MG-QTY 2 @ 6,270.03

Context & Analysis

On Oct 17, 2025, Department of Justice to ACTELION PHARMACEUTICALS US, INC. for opsumit 10mg-qty 2 @ 6,270.03. The award is classified under NAICS 325412 — PHARMACEUTICAL PREPARATION MANUFACTURING and issued as a firm fixed price contract. Competition extent: full and open competition with 1 offer received. Performance is located in TITUSVILLE, NJ.

Contractor Information

UEI: H5BMHLMMNA28
CAGE Code: 33TN9
Location: TITUSVILLE, NJ
View Full Record on USASpending.gov

Stay Updated

Get notified about new opportunities matching your interests.

Related